1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Langfang Meihua Biotechnology Development Co. Ltd. has 1 pending office action. The matter is assigned to 1 examiner, while no distinct art unit is recorded in the profile.
JONES-FOSTER, ERICA NICOLE is the listed examiner and handles the pending matter. Counsel can center prosecution on that examiner’s treatment of the claims while confirming the appropriate examination context during case review.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JONES-FOSTER, ERICA NICOLE | 1 | 49.4% | +44.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18833597 | RECOMBINANT MICROORGANISM FOR PRODUCING THREONINE AND USE THEREOF | JONES-FOSTER, ERICA NICOLE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18833597 | RECOMBINANT MICROORGANISM FOR PRODUCING THREONINE AND USE THEREOF | JONES-FOSTER, ERICA NICOLE | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18833597 | RECOMBINANT MICROORGANISM FOR PRODUCING THREONINE AND USE THEREOF | JONES-FOSTER, ERICA NICOLE | — | §103§112 | Non-Final OA | — | Pending | Jul 26, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialLangfang Meihua Biotechnology Development Co. Ltd. has 1 pending office actions as of October 2026, spread across 0 art units and 1 examiners.
Erica Nicole Jones-Foster has the most, with 1 of Langfang Meihua Biotechnology Development Co. Ltd.'s pending office actions.
